Pink eye – a symptom of COVID-19 von MUNTEAN, Petru E.

Volltext

Isolated intestinal tuberculosis associated with human immunodeficiency virus infection von MUNTEAN, Petru E.

Volltext

Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPS... von Kurtz, J.E., Kaminsky, M.C., Floquet, A., Veillard, A.S., Kimmig, R., Dorum, A., Elit, L., Buck, M., Petru, E., Reed, N., Scambia, G., Varsellona, N., Brown, C., Pujade-Lauraine, E.

Volltext

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Mea... von Friedlander, M., Rau, J., Lee, C.K., Meier, W., Lesoin, A., Kim, J.-W., Poveda, A., Buck, M., Scambia, G., Shimada, M., Hilpert, F., King, M.T., Debruyne, P., Bologna, A., Malander, S., Monk, B.J., Petru, E., Calvert, P., Herzog, T.J., Barrett, C., du Bois, A.

Volltext

Chest Imaging Features Of Covid-19 Pneumonia von MUNTEAN, Petru E., NECULCEA, Cristina G.

Volltext

Successful recovery of COVID-19 pneumonia in a young male with negative COVID-19 IGM/IGG antibody rapid test but positive 2019-NCOV RT-PCR von Petru E. MUNTEAN, Ana-M. MIHAI

Volltext

Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (P... von Sehouli, J., Chekerov, R., Reinthaller, A., Richter, R., Gonzalez-Martin, A., Harter, P., Woopen, H., Petru, E., Hanker, L.C., Keil, E., Wimberger, P., Klare, P., Kurzeder, C., Hilpert, F., Belau, A.K., Zeimet, A., Bover-Barcelo, I., Canzler, U., Mahner, S., Meier, W.

Volltext

Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2- breast cancer von Guarneri, V, Fasching, P A, Fernández Abad, M, García-Saenz, J A, Schneeweiss, A, Colleoni, M, Petru, E, Costigan, T M, Caldwell, C W, Barriga, S, Hurvitz, S, Slamon, D

Volltext

641: Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer von Auer, M, Heitzer, E, Ulz, P, Pristauz, G, Petru, E, Jahn, S, Speicher, M.R, Geigl, J.B

Volltext

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer von Lee, C K, Gurney, H, Brown, C, Sorio, R, Donadello, N, Tulunay, G, Meier, W, Bacon, M, Maenpaa, J, Petru, E, Reed, N, Gebski, V, Pujade-Lauraine, E, Lord, S, Simes, R J, Friedlander, M

Volltext

Interferon‐gamma in combination with carboplatin and paclitaxel as a safe and effective first‐line treatment option for advanced ovarian cancer: results of a phase I/II study von MARTH, C., WINDBICHLER, G.H., HAUSMANINGER, H., PETRU, E., ESTERMANN, K., PELZER, A., MUELLER‐HOLZNER, E.

Volltext

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer von Harter, Philipp, Sehouli, Jalid, Vergote, Ignace, Ferron, Gwenael, Reuss, Alexander, Meier, Werner, Greggi, Stefano, Mosgard, Berit J, Selle, Frederic, Guyon, Frédéric, Pomel, Christophe, Lécuru, Fabrice, Zang, Rongyu, Avall-Lundqvist, Elisabeth, Kim, Jae-Weon, Ponce, Jordi, Raspagliesi, Francesco, Kristensen, Gunnar, Classe, Jean-Marc, Hillemanns, Peter, Jensen, Pernille, Hasenburg, Annette, Ghaem-Maghami, Sadaf, Mirza, Mansoor R, Lund, Bente, Reinthaller, Alexander, Santaballa, Ana, Olaitan, Adeola, Hilpert, Felix, du Bois, Andreas

Volltext

S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013 von Wagner, U, Harter, P, Hilpert, F, Mahner, S, Reuß, A, du Bois, A, Petru, E, Meier, W, Ortner, P, König, K, Lindel, K, Grab, D, Piso, P, Ortmann, O, Runnebaum, I, Pfisterer, J, Lüftner, D, Frickhofen, N, Grünwald, F, Maier, B O, Diebold, J, Hauptmann, S, Kommoss, F, Emons, G, Radeleff, B, Gebhardt, M, Arnold, N, Calaminus, G, Weisse, I, Weis, J, Sehouli, J, Fink, D, Burges, A, Hasenburg, A, Eggert, C

Volltext

Re: Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecolo... von Petru, E., Benedicic, Ch, Huell, A.

Volltext

Langzeitremission bei Anti-erbB2-Therapie mit Lapatinib und Fulvestrant bei immobilisierender Knochenmetastasierung eines Mammacarcinoms von Trutnovsky, G, Petru, E

Volltext

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer von Vergote, Ignace, Tropé, Claes G, Amant, Frédéric, Kristensen, Gunnar B, Ehlen, Tom, Johnson, Nick, Verheijen, René H.M, van der Burg, Maria E.L, Lacave, Angel J, Panici, Pierluigi Benedetti, Kenter, Gemma G, Casado, Antonio, Mendiola, Cesar, Coens, Corneel, Verleye, Leen, Stuart, Gavin C.E, Pecorelli, Sergio, Reed, Nick S

Volltext

Adjuvante Therapie des Endometriumkarzinoms von Mallmann, P., Vordermark, D., Feyer, P., Hagen, V., Höcht, S., Niehoff, P., Petru, E., Zeimet, A.-G., Micke, O., Battista, M. J.

Volltext

Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinu... von Petru, E., Angleitner-Boubenizek, L., Reinthaller, A., Deibl, M., Zeimet, A.G., Volgger, B., Stempfl, A., Marth, C.

Volltext

Long-term Control of Bone Marrow Carcinosis and Severe Thrombocytopenia with Standard-dose Chemotherapy in a Breast Cancer Patient: A Case Report von Bjelic-Radisic, V, Stöger, H, Winter, R, Beham-Schmid, C, Petru, E

Volltext

Re: “Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy” von Petru, E., Petru, C., Benedicic, Ch

Volltext